AzTrials
AzTrials

EmergenciesNCT05680090

Artificial Intelligent System for Eye Emergency Triage and Primary Diagnosis

An observational study of Emergencies and Eye Diseases, run by Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Ophthalmic emergencies are acute vision-threatening disorders, for which a delay in prompt emergency response could result in catastrophic vision loss. Triage is an effective process for ensuring that timely emergency care is provided despite limited resource by prioritizing patients to appropriate orders for visits. Read more about this study

Who is it for?
Any age
Conditions the study is for
Emergencies, Eye Diseases
What is being tested?
Artificial intelligent system for eye emergency triage and primary diagnosis
How many people
100 participants
Where
1 siteChina
Study dates
10 Dec 2022to 20 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Through the online popular science, news reports, and other channels, we will promote and inform patients about the relevant knowledge of ophthalmic emergencies, so that they can judge by themselves and freely decide whether to participate in this study or not.

Who may be able to join

  • Suffering acute ophthalmic symptoms within one month
  • Visiting the ocular emergency department for the first time
  • Must be able to complete the triage form for ophthalmic emergency
  • Must be able to cooperate either by submitting smartphone photographs or receiving slit-lamp examination

Who cannot join

  • The image quality does not meet the clinical requirements.

Trial locations and contacts

1 site in 1 country.

Haotian Lin, M.D., Ph.D contact

8613802793086

haot.lin@hotmail.com

China1 site, 1 recruiting
  • Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity

    Guangzhou, Guangdong, 510060

    Haotian Lin, M.D., Ph.D, 8613802793086, linht5@mail.sysu.edu.cn

    Xiaohang Wu, M.D., Ph.D, 8615913177657, wxhang@mail2.sysu.edu.cn

    Recruiting

Other trials in China

About this study

Official title: Prospective Validation of an Artificial Intelligent System for Eye Emergency Triage and Primary Diagnosis

Ophthalmic emergencies are acute vision-threatening disorders, for which a delay in prompt emergency response could result in catastrophic vision loss. Triage is an effective process for ensuring that timely emergency care is provided despite limited resource by prioritizing patients to appropriate orders for visits. Historically, registered nurses classify emergency patients based on personal experiences with high variation. Additionally, primary healthcare providers have been conventionally at the forefront of providing first aid care. However, most of ocular emergencies are wrongly diagnosed or referred due to non-eye specialists' limited knowledge and training in the ophthalmology.

Here, the investigators established and validated an artificial intelligence system, EE-Explorer, to triage eye emergencies and assist in primary diagnosis using metadata and ocular images. This system has been integrated into a website to be prospectively validated in the real world.

Being tested
Artificial intelligent system for eye emergency triage and primary diagnosis
Keywords
Artificial intelligence, Ophthalmic emergency triage, Primary diagnosis, Multimodal data
Medical subject headings
Emergencies, Eye Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Artificial intelligent system for eye emergency triage and primary diagnosisDiagnostic test

    An intelligent triage and diagnostic system for ophthalmic emergencies has been developed. In the prospective test, patients with acute ocular symptoms can achieve remote self-triage and primary diagnosis after uploading metadata and ocular images.

Study groups in NCT05680090
Study groupRoleWhat they receive
Eligible participants for AI-based ophthalmic emergency triage and primary diagnosisNot described
Receives: Diagnostic Test: Artificial intelligent system for eye emergency triage and primary diagnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The accuracy of the triage model

    Use the triage model to classify patients with acute ocular symptoms, and count the proportion of correct classification.

    Measured: 2023.1

Secondary outcomes (1)
  1. The accuracy of the primary diagnostic model

    Use the primary diagnostic model to diagnose patients with ophthalmic emergencies, and count the proportion of correct diagnosis in all patients.

    Measured: 2023.1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2023
  2. Study start10 Dec 2022
  3. Primary completion13 Jan 2023 (estimated)
  4. Study completion20 Jan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05680090
Sponsor's protocol ID
2021KYPJ046
Status last verified
Dec 2022
First submitted
13 Dec 2022
Last updated
11 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Emergencies and Eye Diseases, run by Sun Yat-sen University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Haotian Lin, M.D., Ph.D (8613802793086, haot.lin@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The accuracy of the triage model (time frame: 2023.1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in